Patient ID : 32387 Patient Ref. No.

: 32387 Lab ID : 31865099

Name : NAGENDRA SINGH Reg. Date : 29-DEC-2018 18:44:46
Date of Birth : 01-DEC-1972 Male Sampling Date : 29-DEC-2018 18:44:46
Ref. Clinic : APPLE CLINIC FZCO SHJ Reviewed Date : 30-DEC-2018 12:19:46
Ref. By : Dr. Mikshaf Butt Approved Date :30-DEC-2018 12:36:03
Ins. Company : Qatar Insurance Company (GN, CN,
SR,EN,RN)
Sample ID : 8123303761, 8123303762
GENERAL LABORATORY REPORT
Test Result Unit Ref. Range Methodology

Alanine Aminotransferase (ALT), Serum 20.0 U/L Less Than 41.0 IFCC

Aspartate Aminotransferase (AST), 26.0 U/L Less Than 40.0 IFCC

Serum

Gamma-Glutamyltransferase (GGT), 20.0 U/L Less Than 60.0 GGCN

Serum

Bilirubin, total, Serum 0.30 mg/dl Less Than 1.40 Diazo

Bilirubin, Direct, Serum 0.12 mg/dl Up To 0.30 Diazo

Albumin, Serum 4.5 g/dl 3.5 - 5.2 ALBUMIN-BCG

COMPLEX,
COLORIMETRY

Creatinine, Serum 0.90 mg/dl 0.70 - 1.20 Photometry

Uric Acid, Serum 5.4 mg/dl 3.4 - 7.0 Colorimetric

Glucose, Fasting, Plasma 85.00 mg/dl Normal: 70-99 Colorimetric

Prediabetes: 100-125
Diabetes: >=126
Reference values according to the American Diabetes association
Lipid Profile

Cholesterol, Total, Serum 172.00 mg/dl Desirable: < 200 Colorimetric

Borderline high: 200-239
high: > 240
According to NCEP

* Reference ranges are adjusted to patient's age and gender whenever applicable

Verified By: : Liezl Naranja Rada Final Report Reviewed By: : Dr Dina Elkhashab
Medical Laboratory Printed on: 12:36 30/12/18 Specialist Clinical
Technologist Pathologist
License No : T45193 Page 1 of 2 License No : D21115
Patient ID : 32387 Patient Ref. No. : 32387 Lab ID : 31865099
Name : NAGENDRA SINGH Reg. Date : 29-DEC-2018 18:44:46
Date of Birth : 01-DEC-1972 Male Sampling Date : 29-DEC-2018 18:44:46
Ref. Clinic : APPLE CLINIC FZCO SHJ Reviewed Date : 30-DEC-2018 12:19:46
Ref. By : Dr. Mikshaf Butt Approved Date :30-DEC-2018 12:36:03
Ins. Company : Qatar Insurance Company (GN, CN,
SR,EN,RN)
Sample ID : 8123303761, 8123303762
GENERAL LABORATORY REPORT
Test Result Unit Ref. Range Methodology

Cholesterol HDL, Serum 43.00 mg/dl <40 Low HDL- Homogeneous

Cholesterol (major risk enzymatic
factor for CHD) colorimetric
>/=60 High HDL-
Cholesterol (negative
risk factor for CHD)
According to NCEP

Cholesterol LDL, Serum 137.0 H mg/dl Optimal: <100 Homogeneous

Near optimal:100-129 enzymatic
Borderline high: 130-159 colorimetric
High: 160-189
Very high: >190
Levels in terms of risk for coronary heart disease.

Triglycerides, Serum 65.00 mg/dl Less Than 150.00 Photometry

According to NCEP

VLDL Cholesterol 13.0 mg/dl 5.0 - 40.0 Calculation

Cholesterol / HDL ratio 4.0 Ratio <5.0 Calculation

LDL / HDL ratio 3.2 Ratio Below Average Risk <3.6 Calculation
End of Report

* Reference ranges are adjusted to patient's age and gender whenever applicable

Verified By: : Liezl Naranja Rada Final Report Reviewed By: : Dr Dina Elkhashab
Medical Laboratory Printed on: 12:36 30/12/18 Specialist Clinical
Technologist Pathologist
License No : T45193 Page 2 of 2 License No : D21115